DaleRandallShepardMDPhD

PubMed

• 39 citations
  A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors.
  Ezra E.W. Cohen, Michael J. Pishvaian, Dale R. Shepard, Ding Wang, Jared Weiss
  Journal for Immunotherapy of Cancer. 2019-12-04
• 58 citations
  Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-Refractory Advanced Solid Tumors
  Filip Janku, Halle H. Zhang, Abdul Mohammad Pezeshki, Sanjay Goel, Ravi Murthy
  Clinical Cancer Research. 2021-01-01
• 42 citations
  Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor
  Angela Joubert James, Catherine C. Smith, Mark R. Litzow, Alexander E. Perl, Jessica K. Altman
  Clinical Pharmacokinetics. 2020-10-01

Journal Articles

• Point/Counter: Can the FDA streamline the approval process?  
  Shepard, D, HemOnc Today, 1/10/2014
• Lack of elderly patients in cancer trials leads to inadequate treatment guidance  
  Shepard, D, HemOnc Today, 8/10/2013
• Despite headlines, role of statins in cancer prevention far from proven  
  Shepard, D, HemOnc Today, 5/25/2013
• Perspective: Surgery after imatinib improved survival for patients with metastatic, recurrent GIST  
  Shepard, D, HemOnc Today, 1/23/2013
• Perspective: Ziv-aflibercept yields encouraging results in metastatic colorectal cancer  
  Shepard, D, HemOnc Today, 10/10/2012
• Point/Counter: Are drug shortages the “new normal” for cancer care?  
  Shepard, D, HemOnc Today, 4/10/2012
• Perspective: Colonoscopic removal of adenomatous polyps reduced colorectal cancer deaths  
  Shepard, D, 2/29/2012
• Perspective: UN mobilizes global governments in fight against non-communicable diseases  
  Shepard, D, 10/25/2011
• Perspective: Tricagrelor: A review of the data leading to FDA approval  
  Shepard, D, 9/25/2011
• Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multforme  
  Peerboom, D.M., Shepard, D.R., Ahluwalia, M.S., Brewer,C.J., Stevens, G.H., Suh, J.H., Toms, S.A., Vogelbaum, M.A., Weil, S.A., Elson, P., Barnett, G.H., J Neurooncol, 1/1/2010
• Toxicity associated with the long-term use of targeted therapies in patients with advanced renal cell carcinoma  
  Shepard, D.R. and Garcia, J. A., Expert Rev. Anticancer Ther, 1/1/2009
• Phase II trial of neoadjuvant nab-paclitaxel in high-risk patients with prostate cancer undergoing radical prostatectomy  
  Shepard, D.R., Dreicer, R., Garcia, J., Elson, P., Magi-Galluzzi, C., Raghavan, D., Stephenson, A.J., Klein, E.A., J. Urol, 1/1/2009
• Biliary transport of irinotecan and metabolites in normal and p-glycoprotein deficient mice  
  Iyer, L., Ramirez, J., Shepard, D.R., Bingham, C.M., Hossfeld, D-K, Ratain, M.J., Mayer, U., Cancer Chemother Pharmacol, 1/1/2002
• Gallium nitrate suppresses the production of nitric oxide and attenuates hepatitis in a murine model of LPS-induced sepsis  
  Krecic-Shepard, M.E., Shepard, D.R., Mullet, D., Apseloff, G., Gerber, N., Life Sciences, 1/1/1999
• A phase II study of oral trimethylcolchicinic acid in patients with hormone refractory prostate cancer  
  Brockstein, B.E., Shepard, D.R., Kugler, J.W., Fishkin, P.A., Arrieta, R., Ratain, M.J., Vokes, E.E., Vogelzang, N.J., Prostate J, 1/1/1999
• The effects of gallium nitrate on osteopenia induced by ovariectomy and a low-calcium diet in rats  
  Stern, L.S., Matkovic, V., Weisbrode, S.E., Apseloff, G., Shepard, D.R., Mays, D.C., Gerber, N, Bone and Mineral, 1/1/1994
• Aminohydoxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats  
  Apseloff, G., Girten, B., Walker, M., Shepard, D.R., Krecic, M.E., Stern, L.S., Gerber, N., J. Pharmacol. Exp. Ther, 1/1/1993
• The effect of gallium nitrate upon bone loss in a rat model of simulated weightlessness  
  Apseloff, G., Girten, B., Gerber, N., Shepard, D., Matkovic, V., Aviat. Space Environ. Med, 1/1/1992
• Effects of gallium nitrate upon bone turnover and serum lipid levels in postmenopausal women  
  Matkovic, V., Apseloff, G., Shepard, D.R., Jelic, T., Gerber, N., Curr. Ther. Res, 1/1/1991
• Aminohydroxybutane bisphosphonate prevents bone loss in a rat model of simulated weightlessness  
  Apseloff, G., Girten, B., Walker, B., Shepard, D.R., Matkovic, V., Stern, L.S., Gerber, N., Curr. Ther. Res, 1/1/1991
• Inhibition and induction of theophylline metabolism by 8-methoxypsoralen: in vivo study in rats and humans  
  Apseloff, G., Shepard, D.R., Chambers, M.A., Nawoot, S., Mays, D.C., Gerber, N, Drug Metab. Dispos, 1/1/1990
• Use of gallium to treat Paget’s disease of bone: a pilot study  
  Matkovic, V., Apseloff, G., Shepard, D.R., Gerber, N., Lancet, 1/1/1990
• Hazards of gallium for Paget’s disease of bone [Letter]  
  Matkovic, V., Apseloff, G., Shepard, D.R., Gerber, N., Lancet, 1/1/1990
• Join now to see all